PEPT
PEPT

Peptide Development Labs Inc.

Status
Active
Issued & Outstanding37,511,506
Reserved for Issuance3,000,000
Currency
CSE Index

About

Peptide Development Labs Inc.

Listing Date
November 20, 2026
Peptide Development Labs Inc. is a Canadian pharmaceutical development company focused on advancing investigational peptide-based drug candidates through established regulatory pathways. The Issuer’s mission is to develop peptide candidates that may address defined areas of unmet clinical need within a conventional pharmaceutical framework. To achieve this, the Issuer focuses on advancing its investigational subcutaneous BPC-157 drug candidate for refractory ligament disorders through GMP-controlled supply, pharmaceutical quality systems, physician-led access, structured data generation and formal clinical development.